185.40p-2.00 (-1.07%)17 Apr 2025, 16:46
Jump to:
Spire Healthcare Group PLC Fundamentals
Company Name | Spire Healthcare Group PLC | Last Updated | 2025-04-17 |
---|---|---|---|
Industry | Medical Care Facilities | Sector | Healthcare |
Shares in Issue | 402.371 m | Market Cap | £746.00 m |
PE Ratio | 29.90 | Dividend per Share | £0.02 |
Dividend Yield | 1.13 | Dividend Cover | 2.95 |
EPS | £0.06 | EPS Growth (%) | 0.04 |
PEG | 0 | DPS Growth (%) | 3.2000 |
Debt Ratio | 0.5462 | Debt Equity Ratio | 1.5693 |
Asset Equity Ratio | 3.1402 | Cash Equity Ratio | 0.0586 |
Quick Ratio | 0.4361 | Current Ratio | 0.66 |
Price To Book Value | 0.9968 | ROCE | 0 |
Spire Healthcare Group PLC Dividends
Type | Ex-Date | Pay Date | Currency | Net Dividend | Year Total |
---|---|---|---|---|---|
Prelim | 2025-05-22 | 2025-06-20 | GBP | 0.0230 | |
Prelim | 2024-05-23 | 2024-06-21 | GBP | 0.0210 | |
Prelim | 2023-05-25 | 2023-06-23 | GBP | 0.0050 |
Spire Healthcare Group PLC Company Financials
Assets | 2024 | 2023 | 2022 |
---|---|---|---|
Tangible Assets | £1.66 bn | £1.62 bn | £1.58 bn |
Intangible Assets | £437.40 m | £438.30 m | £345.80 m |
Investments | £12.30 m | £10.00 m | £4.60 m |
Total Fixed Assets | £2.12 bn | £2.07 bn | £1.94 bn |
Stocks | £46.60 m | £44.30 m | £40.60 m |
Debtors | £105.30 m | £99.70 m | £84.80 m |
Cash & Equivalents | £43.70 m | £49.60 m | £74.20 m |
Other Assets | £4.80 m | £400,000.00 | £5.00 m |
Total Assets | £2.34 bn | £2.29 bn | £2.16 bn |
Liabilities | 2024 | 2023 | 2022 |
---|---|---|---|
Creditors within 1 year | £341.70 m | £317.60 m | £283.40 m |
Creditors after 1 year | £1.26 bn | £1.23 bn | £1.15 bn |
Other Liabilities | 0 | 0 | 0 |
Total Liabilities | £1.60 bn | £1.55 bn | £1.43 bn |
Net assets | £746.20 m | £737.80 m | £725.10 m |
Equity | 2024 | 2023 | 2022 |
---|---|---|---|
Called up share capital | £4.00 m | £4.00 m | £4.00 m |
Share Premium | £830.00 m | £830.00 m | £830.00 m |
Profit / Loss | £38.30 m | £34.60 m | £3.90 m |
Other Equity | £748.40 m | £739.90 m | £731.00 m |
Preference & Minorities | -£2.20 m | -£2.10 m | -£5.90 m |
Total Capital Employed | £746.20 m | £737.80 m | £725.10 m |
Ratios | 2024 | 2023 | 2022 |
---|---|---|---|
Debt Ratio | £0.61 | £0.61 | £0.60 |
Debt-to-Equity | £1.57 | £1.56 | £1.50 |
Assets / Equity | 3.1402 | 3.1402 | 3.1402 |
Cash / Equity | 0.0586 | 0.0586 | 0.0586 |
EPS | £0.07 | £0.07 | £0.01 |
Cash Flow | 2024 | 2023 | 2022 |
---|---|---|---|
Cash from operating activities | £235.70 m | £215.50 m | £181.60 m |
Cashflow before financing | £90.60 m | £132.60 m | -£33.10 m |
Increase in Cash | -£8.40 m | -£24.60 m | -£128.40 m |
Income | 2024 | 2023 | 2022 |
---|---|---|---|
Turnover | £1.51 bn | £1.36 bn | £1.20 bn |
Cost of sales | £827.60 m | £734.80 m | £660.10 m |
Gross Profit | £683.60 m | £624.20 m | £538.40 m |
Operating Profit | £137.50 m | £126.20 m | £95.40 m |
Pre-Tax profit | £38.30 m | £34.60 m | £3.90 m |
Spire Healthcare Group PLC Company Background
Sector | Healthcare |
---|---|
Activities | Spire Healthcare Group PLC is an independent hospital group in the United Kingdom, with 40 private hospitals and eight clinics. It is a private provider, by volume, of knee and hip operations in the United Kingdom. The company has three operating segments being the hospitals business, Vita Health Group and The Doctors Clinic Group. The company has aggregated Vita Health Group and The Doctors Clinic Group into one reportable segment called primary care. The company generates the majority of its revenue from Hospital Business, which consists of hospitals, clinics, medical centres and consulting rooms. The company provide diagnostics, inpatient, day case and outpatient care in areas including orthopaedics, gynaecology, cardiology, neurology, oncology and general surgery. |
Latest Interim Date | 12 Sep 2024 |
Latest Fiscal Year End Date | 6 Mar 2025 |
Spire Healthcare Group PLC Directors
Appointed | Name | Position |
---|---|---|
2019-05-16 | Mr. Peter Richard Bamford | Non-Executive Director,Deputy Chairman |
2016-06-27 | Mr. Robert Earl Lerwill | Non-Executive Director |
2018-04-19 | Mr. Andrew White | Executive Director |
2017-05-26 | Mr. John Gildersleeve | Non-Executive Director,Deputy Chairman |
2022-04-01 | Mr. Garry Watts MBE | Non-Executive Director,Chairman |
2018-04-19 | Mr. Simon Gordon | Executive Director,Chief Financial Officer |
2025-04-08 | Sir Ian Michael Cheshire | Non-Executive Director,Chairman |
2017-04-25 | Mr. Robert Roger | Executive Director,Chief Executive Officer |
2025-04-08 | Mr. Anthony Rhys Bourne | Non-Executive Director |
2024-04-04 | Mr. Jitesh Himatlal Sodha | Executive Director,Chief Financial Officer |
2024-04-04 | Ms. Adele Helen Anderson | Non-Executive Director |
2024-04-04 | Mr. Simon Nicholas Rowlands | Non-Executive Director |
2015-07-01 | Dr. Supraj Rajagopalan | Non-Executive Director |
2025-04-08 | Professor Dame Janet Elizabeth Husband | Non-Executive Director,Vice Chairman |
2025-03-07 | Ms. Debra Jayne White | Non-Executive Director,Senior Independent Director |
2025-04-10 | Mr. Justinian Joseph Ash | Executive Director,Chief Executive Officer |
2025-04-08 | Ms. Jenny Kay | Non-Executive Director |
2025-04-10 | Mr. Harbant Samra | Executive Director,Chief Financial Officer |
Spire Healthcare Group PLC Contact Details
Company Name | Spire Healthcare Group PLC |
---|---|
Address | 3 Dorset Rise, London, EC4Y 8EN |
Telephone | |
Website | https://www.spirehealthcare.com |
Spire Healthcare Group PLC Advisors
Stockbroker | J.P. Morgan Cazenove Ltd |
---|---|
Phone | +44 2077424000 |
Remuneration Consultant | Deloitte LLP |
---|---|
Phone | +44 2079363000 |
Fax | +44 2075831198 |
Stockbroker | Bank of America Merrill Lynch |
---|---|
Phone | +44 2076281000 |
Fax | +44 2078672867 |
Financial PR Adviser | Maitland |
---|---|
Phone | +44 2073795151 |
Fax | +44 2073796161 |
Solicitor | Freshfields Bruckhaus Deringer |
---|---|
Phone | +44 2079364000 |
Fax | +44 2078327001 |
Registrar | Equiniti Limited |
---|
Solicitor | Allen & Overy LLP |
---|---|
Phone | +44 2030880000 |
Fax | +44 207339999 |
Auditor | EY |
---|---|
Phone | +44 2079512000 |
Fax | +44 2079511345 |
Most Read
Receive our
daily news email
Subscribe to the latest investing news by entering your email address below
You can opt out at any time.
For five days a week you will get
- The latest company news
- Insight into investment trends
- Round-up of director's buys and sells
- Articles from Shares magazine

Plus more useful investment content and occasional promotional offers.
Market Overview
UK 350 Risers and Fallers
Risers
Company | Price | % Chg |
---|---|---|
Dunelm Group PLC | 1,074.00 | 13.29 |
Asos PLC | 313.50 | 6.63 |
Rentokil Initial PLC | 350.00 | 5.01 |
Sainsbury (J) PLC | 256.80 | 3.55 |
Dr. Martens PLC | 52.80 | 3.53 |
Pershing Square Holdings LTD | 3,414.00 | 3.45 |
Fallers
Company | Price | % Chg |
---|---|---|
Dowlais Group PLC | 51.40 | -6.03 |
Fresnillo PLC | 1,021.00 | -5.55 |
Jupiter Fund Management PLC | 69.30 | -5.07 |
Goodwin PLC | 6,780.00 | -4.51 |
Spectris PLC | 1,987.00 | -4.38 |
Twentyfour Income Fund Limited | 108.60 | -3.89 |
Risers/fallers data from previous trading day. Today's data available from 8:15am.